• Correction: Hospital Superbug Outbreak story

    LOS ANGELES (AP) — In a Feb. 20, 2015 story about an antibiotic-resistant “superbug” outbreak at Ronald Reagan UCLA Medical Center, The Associated Press mischaracterized a statement an expert made about proving the cause of an infection. Lawrence Muscarella, a health care and sterilization expert, said he was suggesting an argument hospitals might use when he said, “Proving causation is impossible.” Muscarella said an infection can be proven to come from a hospital instrument.

  • This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan, now in the crosshairs over severe price hikes for its EpiPen, said Thursday, Aug. 25, 2016, it will expand programs that lower out-of-pocket costs by as much as half. (AP Photo/Mark Zaleski, File)

    Mylan boosts EpiPen patient programs, doesn’t budge on price

    The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price.

  • In this Friday, July 8, 2016 photo, a pharmacist holds a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions, in Sacramento, Calif. Price hikes for the emergency medicine have made its maker, Mylan, the latest target for patients and politicians infuriated by soaring drug prices. (AP Photo/Rich Pedroncelli)

    How EpiPen’s maker raised prices, and hackles, so much

    TRENTON, N.J. (AP) — Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.